Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome

Nutrition Research

Volumn 31, Issue 2, 2011, Pages 97-103

  Toscani, Mariana K ^a,b,c   Mario, Fernanda M ^a,b,c   Radavelli Bagatini, Simone ^a,b,c   Spritzer, Poli Mara ^a,b,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c National Institute of Hormones and Women's Health CNPq   (Brazil)

Author keywords

Central obesity; Food intake; Insulin resistance; Nutritional sciences; Sex steroid hormones; Women

Indexed keywords

ANDROGEN; CARBOHYDRATE; FAT; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CASE CONTROL STUDY; CENTRAL OBESITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LABORATORY TEST; MACRONUTRIENT; METABOLIC REGULATION; NUTRITIONAL ASSESSMENT; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; PROTEIN INTAKE; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ANDROGENS; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; DIET; ENERGY INTAKE; FEMALE; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN RESISTANCE; NUTRITION ASSESSMENT; OBESITY; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TRIGLYCERIDES; YOUNG ADULT;

EID: 79952688061     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.01.009     Document Type: Article

References (58)

1. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83:3078-3082.
2. Asuncion M., Calvo R.M., San Millán J.L., Sancho J., Avila S., Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000, 85:2434-2438.
3. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004, 89:2745-2749.
4. Spritzer P.M., Wiltgen D. Prevalence of metabolic syndrome in patients of south of Brazil with polycystic ovary syndrome (PCOS). Arq Bras Endocrinol Metabol 2007, 51:146-147.
5. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
6. Spritzer P.M., Poy M., Wiltgen D., Mylius L.S., Capp E. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements. Hum Reprod 2001, 16:1340-1346.
7. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009, 91:456-488. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society.
8. Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 1996, 10:221-247.
9. Wiltgen D., Benedetto I.G., Mastella L.S., Spritzer P.M. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 2009, 24:1726-1731.
10. Burghen G.A., Givens J.R., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980, 50:113-116.
11. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18:774-800.
12. Yildiz B.O., Yarali H., Oguz H., Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003, 88:2031-2036.
13. Legro R.S., Driscoll D., Strauss J.F., Fox J., Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 1998, 95:14956-14960.
14. Douglas C.C., Norris L.E., Oster R.A., Darnell B.E., Azziz R., Gower B.A. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertil Steril 2006, 86:411-417.
15. Holte J., Bergh T., Berne C., Wide L., Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995, 80:2586-2593.
16. Alves A.L., Olinto M.T., Costa J.S., Bairros F.S., Balbinotti M.A. Dietary patterns of adult women living in an urban area of Southern Brazil. Rev Saude Publica 2006, 40:865-873.
17. Nutrition and reproduction in women. Hum Reprod Update 2006, 12:193-207. ESHRE Capri Workshop Group.
18. Marsh K., Brand-Miller J. The optimal diet for women with polycystic ovary syndrome?. Br J Nutr 2005, 94:154-165.
19. Pasquali R., Pelusi C., Ragazzini C., Hasanaj R., Gambineri A. Glucose tolerance, insulin secretion and insulin sensitivity in polycystic ovary syndrome. JOP 2002, 3:1-7.
20. Hoeger K. Obesity and weight loss in polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001;28:85-97, vi-vii.
21. Spritzer P., Billaud L., Thalabard J.C., Birman P., Mowszowicz I., Raux-Demay M.C., et al. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab 1990, 70:642-646.
22. Donato G.B., Fuchs S.C., Oppermann K., Bastos C., Spritzer P.M. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause 2006, 13:280-285.
23. Toscani M., Migliavacca R., Sisson de Castro J.A., Spritzer P.M. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Metabolism 2007, 56:992-997.
24. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995, 854:1-452.
25. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:I-xii, 1-253.
26. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21:1440-1447.
27. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006, 91:4237-4245. Androgen Excess Society.
28. Moran L.J., Pasquali R., Teede H.J., Hoeger K.M., Norman R.J. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009, 92:1966-1982.
29. Expert Panel on Detection , Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
30. World Heath Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: report of a WHO consultation: diagnosis and classification of diabetes mellitus 1999, WHO, Geneva.
31. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
32. Wiltgen D., Spritzer P.M. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes. Fertil Steril 2010, 94:2493-2496.
33. Nácul A.P., Andrade C.D., Schwarz P., de Bittencourt P.I., Spritzer P.M. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur J Obstet Gynecol Reprod Biol 2007, 133:191-196.
34. Jonnalagadda S.S., Mitchell D.C., Smiciklas-Wright H., Meaker K.B., Van Heel N., Karmally W., et al. Accuracy of energy intake data estimated by a multiple-pass, 24-hour dietary recall technique. J Am Diet Assoc 2000, 100:303-308. quiz 309-11.
35. Subar A.F., Kipnis V., Troiano R.P., Midthune D., Schoeller D.A., Bingham S., et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 2003, 158:1-13.
36. Wright J.D., Borrud L.G., McDowell M.A., Wang C.Y., Radimer K., Johnson C.L. Nutrition assessment in the National Health and Nutrition Examination Survey 1999-2002. J Am Diet Assoc 2007, 107:822-829.
37. Maroni B.J., Steinman T.I., Mitch W.E. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985, 27:58-65.
38. Fisberg R.M., Colucci A.C., Morimoto J.M., Marchioni D.M. Food frequency questionnaire for adults from a population-based study. Rev Saude Publica 2008, 42:550-554.
39. National Institutes of Health, National Heart, Lung, and Blood institute, North American Association for the Study of Obesity The practical guide: identification, evaluation and treatment of overweight and obesity in adults. Bethesda 2000, 1-80.
40. Sposito A.C., Caramelli B., Fonseca F.A., Bertolami M.C., Afiune Neto A., Souza A.D., et al. Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2007, 88(Suppl 1):2-19.
41. Pasquali R., Casimiri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol (Oxf) 1993, 39:1-16.
42. Gambineri A., Pelusi C., Vicennati V., Pagotto U., Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 2002, 26:883-896.
43. Wild R.A., Painter P.C., Coulson P.B., Carruth K.B., Ranney G.B. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985, 61:946-951.
44. Carmina E., Legro R.S., Stamets K., Lowell J., Lobo R.A. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 2003, 18:2289-2293.
45. McKittrick M. Diet and polycystic ovary syndrome. Nutr Today 2002, 37:63-69.
46. Holte J., Bergh T., Gennarelli G., Wide L. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol (Oxf) 1994, 41:473-481.
47. Ravussin E., Zawadzki J.K. Thermic effect of glucose in obese subjects with non-insulin-dependent diabetes mellitus. Diabetes 1987, 36:1441-1447.
48. Robinson S., Chan S.P., Spacey S., Anyaoku V., Johnston D.G., Franks S. Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol (Oxf) 1992, 36:537-543.
49. Segal K.R., Dunaif A. Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome. Int J Obes 1990, 14:559-567.
50. Michels K.B., Greenland S., Rosner B.A. Does body mass index adequately capture the relation of body composition and body size to health outcomes?. Am J Epidemiol 1998, 147:167-172.
51. Molarius A., Seidell J.C., Sans S., Tuomilehto J., Kuulasmaa K. Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA Project. Int J Obes Relat Metab Disord 1999, 23:116-125.
52. Laughlin G.A., Morales A.J., Yen S.S. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab 1997, 82:1692-1696.
53. Moran L., Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 2009, 15:477-488.
54. Barr V.A., Malide D., Zarnowski M.J., Taylor S.I., Cushman S.W. Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology 1997, 138:4463-4472.
55. Kiddy D.S., Sharp P.S., White D.M., Scanlon M.F., Mason H.D., Bray C.S., et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) 1990, 32:213-220.
56. Legro R.S., Kunselman A.R., Dodson W.C., Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999, 84:165-169.
57. Puder J.J., Varga S., Kraenzlin M., De Geyter C., Keller U., Müller B. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 2005, 90:6014-6021.
58. Schaefer E.J., Lamon-Fava S., Spiegelman D., Dwyer J.T., Lichtenstein A.H., McNamara J.R., et al. Changes in plasma lipoprotein concentrations and composition in response to a low-fat, high-fiber diet are associated with changes in serum estrogen concentrations in premenopausal women. Metabolism 1995, 44:749-756.